Influenza Vaccines
IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza
Published in Vaccine Weekly, December 22nd, 2010
About IDRI - Translating science into global health solutions
IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty. By integrating capabilities -- including preclinical vaccinology, manufacturing, and clinical trials -- IDRI strives to create an efficient pathway bringing scientific innovation from the lab to the people who need it most.
For...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-12-22)
More Articles from Vaccine Weekly
- Tuberculosis
Scientists at University of Cape Town detail research in tuberculosis - Pediatric Vaccines
Studies from University of Michigan in the area of pediatric vaccines published - Cancer Vaccines
Advaxis to Present at the LD Micro Conference - Vaccines
Chinese Markets for Vaccines - Historical Data and Long-Term Forecasts Through to 2019 - Gene Therapy
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B - Vaccines
Emergent BioSolutions to Webcast Presentation at JPMorgan Healthcare Conference - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
